Oncology
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
Researchers from the University of Trento have found that specific changes in gut microbiota composition are associated with colorectal cancer.
Scientists may have just figured out how colibactin, a DNA-damaging molecule produced by certain strains of E. coli, contributes to colorectal cancer.
In precision cancer care, the microbiota cannot be put aside. We talked about this with James Kinross from the Imperial College London.
Lung bacteria can cause inflammation associated with lung cancer by activating the host’s immune system, researchers reported in the journal Cell.
According to J. Kinross, from Imperial College London, there's an urgent need to understand the role of the intestinal microbiome in the etiology of cancer.
We discuss how microbiota could represent a resource for the development of new therapies for cancer patients with prof. Nissan Yissachar (Israel).
The microbiota of a cancerous pancreas is different and larger than that of a non-cancerous pancreas, according to a study published in Cancer Discovery.
We asked Laurence Zitvogel about the advances in the field of oncological immunotherapy and the role of microbiome.
According to a study led by Geoffrey Hannigan of the University of Michigan, the virome of colorectal cancer patients is altered.
